Nuclear factor-E2-related factor 2 (Nrf2) is a transcription factor that promotes antioxidant responses. Nrf2 binds to the E3 ubiquitin ligase adaptor protein Keap1 and is subsequently ubiquitinated and degraded by the proteasome. Sulforaphane (SFN), a compound found in broccoli sprouts, has been shown to activate Nrf2 by inactivating Keap1. We previously demonstrated that Nrf2 stability was also regulated by WDR23 independently of Keap1. In this study, SFN treatment significantly increased Nrf2 protein levels in A549 cells harboring a loss-of-function Keap1 mutation, supporting a Keap1-independent component of Nrf2 regulation. Based on these findings, we focused on the PI3K/AKT/FOXO pathway as a candidate mechanism underlying SFN-induced Nrf2 upregulation. Co-treatment with SFN and either a PI3K or an AKT inhibitor significantly suppressed SFN-induced Nrf2 accumulation. Moreover, immunoblotting suggested that SFN altered FOXO3A phosphorylation in an AKT inhibitor-sensitive manner. SFN also decreased the protein levels of DDB1 and CUL4, core components of the WDR23 E3 ubiquitin ligase complex. Together, these findings are consistent with the possible involvement of AKT/FOXO/DDB1/WDR23-related signaling in SFN-induced Nrf2 accumulation. Because SFN has been reported to exert anti-inflammatory effects, we examined its effects on LPS-induced inflammatory gene expression. SFN reduced LPS-induced interleukin (IL)-1β gene expression in Hep3B and A549 cells. In addition, Nrf2 overexpression was associated with reduced IL-1β gene expression. Taken together, these findings indicate that SFN-induced Nrf2 upregulation is associated with suppression of IL-1β gene expression.